Mizuho Trust & Banking’s Haemonetics HAE Stock Holding History

Mizuho Trust & Banking’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-111,712	Closed	-$4.62M	–	848
2015 Q2	$4.62M	Sell	111,712 -57,840	-34%	-$2.44M	0.02%	644
2015 Q1	$7.62M	Sell	169,552 -16,307	-9%	-$682K	0.03%	594
2014 Q4	$6.96M	Hold	185,859	–	–	0.02%	602
2014 Q3	$6.47M	Sell	185,859 -143,185	-44%	-$5.11M	0.02%	597
2014 Q2	$11.6M	Sell	329,044 -89,309	-21%	-$2.98M	0.04%	474
2014 Q1	$13.6M	Sell	418,353 -9,247	-2%	-$353K	0.05%	410
2013 Q4	$18M	Hold	427,600	–	–	0.07%	326
2013 Q3	$17.7M	Hold	427,600	–	–	0.07%	309
2013 Q2	$17.7M	Buy	+427,600	New	+$17.3M	0.07%	306

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mizuho Trust & Banking's HAE Position: Q3 2015 in Review

Mizuho Trust & Banking sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 111,712 shares — an estimated $4.62M sold.

Mizuho Trust & Banking first reported a position in HAE in Q2 2013 and held it in 9 quarters. The position peaked at $18M in Q4 2013. 172 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

Mizuho Trust & Banking reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
Mizuho Trust & Banking sold 111,712 Haemonetics shares in Q3 2015, an estimated $4.62M.
Mizuho Trust & Banking first reported a position in Haemonetics in Q2 2013 and held it in 9 quarters.
Mizuho Trust & Banking's Haemonetics position peaked at $18M in Q4 2013.
172 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on Mizuho Trust & Banking's 13F filing for Q3 2015, filed 12 Nov 2015.